ABVC Biopharma Inc Financial Flexibility Index
ABVC Biopharma Inc financial flexibility index. ABVC Biopharma Inc (ABVC) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $0.00 (operating CF $-244.41K minus capex $244.41K) represents 0% of total liabilities ($7.13 Million). See ABVC Biopharma Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ABVC Biopharma Inc (2002–2025)
Financial flexibility index of ABVC Biopharma Inc from 2002 to 2025. Historical Financial Flexibility Index trend for ABVC Biopharma Inc across 22 annual periods. Check ABVC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
ABVC Biopharma Inc Financial Flexibility Index by Year (2002–2025)
ABVC Biopharma Inc financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for ABVC Biopharma Inc. For the full cash flow conversion analysis, see ABVC Biopharma Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.38x | $-2.98 Million | $-2.99 Million | $7.76 Million | ▼ -44.6% |
| 2024 | -0.27x | $-1.81 Million | $-1.81 Million | $6.82 Million | ▲ +58.4% |
| 2023 | -0.64x | $-4.17 Million | $-4.19 Million | $6.53 Million | ▲ +44.4% |
| 2022 | -1.15x | $-7.28 Million | $-7.40 Million | $6.34 Million | ▲ +26.9% |
| 2021 | -1.57x | $-7.58 Million | $-7.60 Million | $4.83 Million | ▼ -208.9% |
| 2020 | -0.51x | $-4.55 Million | $-4.56 Million | $8.94 Million | ▼ -15.0% |
| 2019 | -0.44x | $-3.12 Million | $-3.13 Million | $7.05 Million | ▼ -321.7% |
| 2018 | -0.10x | $-612.69K | $-630.20K | $5.85 Million | ▲ +74.2% |
| 2017 | -0.41x | $-1.68 Million | $-1.68 Million | $4.14 Million | ▲ +23.6% |
| 2016 | -0.53x | $-3.47 Million | $-3.47 Million | $6.54 Million | ▼ -719.2% |
| 2015 | 0.09x | $3.36K | $3.36K | $39.15K | ▼ -85.9% |
| 2014 | 0.61x | $20.71K | $1.17K | $34.03K | ▲ +171.9% |
| 2011 | -0.85x | $-1.55 Million | $-1.59 Million | $1.83 Million | ▼ -168.6% |
| 2010 | -0.32x | $-1.04 Million | $-1.05 Million | $3.29 Million | ▲ +46.8% |
| 2009 | -0.59x | $-1.50 Million | $-1.56 Million | $2.53 Million | ▲ +23.5% |
| 2008 | -0.77x | $-2.12 Million | $-2.34 Million | $2.74 Million | ▲ +72.8% |
| 2007 | -2.84x | $-2.60 Million | $-2.69 Million | $913.84K | ▼ -716.3% |
| 2006 | 0.46x | $24.45K | $24.45K | $53.07K | ▲ +106.8% |
| 2005 | -6.77x | $-18.43K | $-18.43K | $2.72K | ▼ -169.5% |
| 2004 | -2.51x | $-7.45K | $-7.45K | $2.96K | ▼ -21329.4% |
| 2003 | 0.01x | $355.00 | $355.00 | $30.00K | ▲ +103.5% |
| 2002 | -0.33x | $-10.00K | $-10.00K | $30.00K | — |